A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

被引：0

作者：

Soukupova, Jana ^{[1
,2
]}

Stastna, Barbora ^{[1
,2
,3
,4
]}

Kanwal, Madiha ^{[3
]}

Hojny, Jan ^{[2
,5
]}

Zemankova, Petra ^{[1
,2
,6
]}

Borecka, Marianna ^{[1
,2
]}

Cerna, Leona ^{[7
]}

Cerna, Marta ^{[1
,2
]}

Cerna, Monika ^{[8
]}

Curtisova, Vaclava ^{[9
]}

Dolezalova, Tatana ^{[1
,2
]}

Duskova, Petra ^{[10
]}

Foretova, Lenka ^{[11
]}

Havranek, Ondrej ^{[2
,12
,13
]}

Horackova, Klara ^{[1
,2
]}

Hovhannisyan, Milena ^{[1
,2
]}

Hruskova, Lucie ^{[14
]}

Chvojka, Stepan ^{[7
]}

Janatova, Marketa ^{[1
,2
]}

Janikova, Maria ^{[9
]}

Jelinkova, Sandra ^{[1
,2
]}

Just, Pavel ^{[1
,2
]}

Kalousova, Marta ^{[1
,2
]}

Kleiblova, Petra ^{[1
,2
,12
]}

Kosarova, Marcela ^{[15
]}

Koudova, Monika ^{[7
]}

Kral, Jan ^{[1
,2
]}

Krausova, Michaela ^{[2
,5
]}

Krutilkova, Vera ^{[16
]}

Machackova, Eva ^{[11
]}

Matejkova, Katerina ^{[1
,2
,17
]}

Michalovska, Renata ^{[14
]}

Nehasil, Petr ^{[1
,2
,6
,18
]}

Nemcova, Barbora ^{[1
,2
]}

Novotny, Jan ^{[2
,12
,19
]}

Palek, Matous ^{[3
]}

Pesek, Pavel ^{[1
,2
]}

Safarikova, Marketa ^{[1
,2
]}

Scheinost, Ondrej ^{[10
]}

Springer, Drahomira ^{[1
,2
]}

Stolarova, Lenka ^{[3
]}

Stranecky, Viktor ^{[2
,18
]}

Subrt, Ivan ^{[8
]}

Tavandzis, Spiros ^{[16
]}

Tureckova, Eva ^{[1
,2
]}

Vesela, Kamila ^{[2
,12
]}

Vlckova, Zdenka ^{[14
]}

Vocka, Michal ^{[2
,20
]}

Zima, Tomas ^{[1
,2
]}

Macurek, Libor ^{[3
]}

机构：

[1] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Katerinska 32, Prague 12108, Czech Republic

[2] Gen Univ Hosp Prague, Katerinska 32, Prague 12108, Czech Republic

[3] Czech Acad Sci, Inst Mol Genet, Lab Canc Cell Biol, Videnska 1034, Prague 14220, Czech Republic

[4] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic

[5] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic

[6] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague, Czech Republic

[7] Ctr Med Genet & Reprod Med, GENNET, Prague, Czech Republic

[8] Univ Hosp Plzen, Inst Med Genet, Plzen, Czech Republic

[9] Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Med Genet, Olomouc, Czech Republic

[10] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic

[11] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic

[12] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic

[13] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic

[14] GHC Genet, Dept Med Genet, Prague, Czech Republic

[15] Pronatal, Dept Med Genet, Prague, Czech Republic

[16] AGEL Res & Training Inst, Dept Med Genet, AGEL Labs, Novy Jicin, Czech Republic

[17] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic

[18] Charles Univ Prague, Dept Paediat & Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic

[19] Inst Clin & Expt Med, Prague, Czech Republic

[20] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

CANCER MEDICINE | 2024年 / 13卷 / 16期

关键词：

breast cancer; Fanconi anemia complementation group G; functional analysis; germline genetic testing; hereditary tumors; ovarian cancer; ANEMIA; ASSOCIATION; REPAIR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes (BRCA1/FANCS, BRCA2/FANCD1, PALB2/FANCN, BRIP1/FANCJ, and RAD51C/FANCO) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear. Methods: Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk. Results: The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss-of-heterozygosity of the wild-type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations. Conclusion: Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

引用

页数：9

共 50 条

[41] Identification of germline cancer predisposition variants during clinical ctDNA testing
Stout, Leigh Anne
Kassem, Nawal
Hunter, Cynthia
Philips, Santosh
Radovich, Milan
Schneider, Bryan P.
SCIENTIFIC REPORTS, 2021, 11 (01)
[42] Identification of germline cancer predisposition variants during clinical ctDNA testing
Leigh Anne Stout
Nawal Kassem
Cynthia Hunter
Santosh Philips
Milan Radovich
Bryan P. Schneider
Scientific Reports, 11
[43] INHERITED PREDISPOSITION TO BREAST AND OVARIAN-CANCER
ROWELL, S
NEWMAN, B
BOYD, J
KING, MC
AMERICAN JOURNAL OF HUMAN GENETICS, 1994, 55 (05) : 861 - 865
[44] Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort
Aleksander Myszka
Pawel Karpinski
Ryszard Slezak
Halina Czemarmazowicz
Agnieszka Stembalska
Justyna Gil
Izabela Laczmanska
Damian Bednarczyk
Elzbieta Szmida
Maria Malgorzata Sasiadek
Journal of Applied Genetics, 2011, 52 : 185 - 191
[45] Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort
Myszka, Aleksander
Karpinski, Pawel
Slezak, Ryszard
Czemarmazowicz, Halina
Stembalska, Agnieszka
Gil, Justyna
Laczmanska, Izabela
Bednarczyk, Damian
Szmida, Elzbieta
Sasiadek, Maria Malgorzata
JOURNAL OF APPLIED GENETICS, 2011, 52 (02) : 185 - 191
[46] Germline BRCA variants, lifestyle and ovarian cancer survival
Gersekowski, Kate
Delahunty, Rachel
Alsopb, Kathryn
Goode, Ellen L.
Cunningham, Julie M.
Winham, Stacey J.
Pharoah, Paul
Song, Honglin
Jordan, Susan
Fereday, Sian
DeFazio, Anna
Friedlander, Michael
Obermair, Andreas
Webb, Penelope M.
GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 437 - 445
[47] Integrated analysis of germline and somatic variants in ovarian cancer
Krishna L. Kanchi
Kimberly J. Johnson
Charles Lu
Michael D. McLellan
Mark D. M. Leiserson
Michael C. Wendl
Qunyuan Zhang
Daniel C. Koboldt
Mingchao Xie
Cyriac Kandoth
Joshua F. McMichael
Matthew A. Wyczalkowski
David E. Larson
Heather K. Schmidt
Christopher A. Miller
Robert S. Fulton
Paul T. Spellman
Elaine R. Mardis
Todd E. Druley
Timothy A. Graubert
Paul J. Goodfellow
Benjamin J. Raphael
Richard K. Wilson
Li Ding
Nature Communications, 5
[48] Integrated analysis of germline and somatic variants in ovarian cancer
Kanchi, Krishna L.
Johnson, Kimberly J.
Lu, Charles
McLellan, Michael D.
Leiserson, Mark D. M.
Wendl, Michael C.
Zhang, Qunyuan
Koboldt, Daniel C.
Xie, Mingchao
Kandoth, Cyriac
McMichael, Joshua F.
Wyczalkowski, Matthew A.
Larson, David E.
Schmidt, Heather K.
Miller, Christopher A.
Fulton, Robert S.
Spellman, Paul T.
Mardis, Elaine R.
Druley, Todd E.
Graubert, Timothy A.
Goodfellow, Paul J.
Raphael, Benjamin J.
Wilson, Richard K.
Ding, Li
NATURE COMMUNICATIONS, 2014, 5
[49] Prevalence of germline variants in inflammatory breast cancer
Rana, Huma Q.
Sacca, Rosalba
Drogan, Christine
Gutierrez, Stephanie
Schlosnagle, Emily
Regan, Meredith M.
Speare, Virginia
LaDuca, Holly
Dolinsky, Jill
Garber, Judy E.
Overmoyer, Beth A.
CANCER, 2019, 125 (13) : 2194 - 2202
[50] ATM germline variants and male breast cancer
Cunha, Renato
Nejo, Priscila
Bento, Sandra
Vaz, Fatima
BMJ CASE REPORTS, 2021, 14 (01)

← 1 2 3 4 5 →